Ependymoma

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

Pharmacoscopy for Patients With Refractory Primary Brain Tumors

Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

Methionine PET/CT Studies In Patients With Cancer

Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma

Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors

Rare CNS Tumors Outcomes &Risk

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma

Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG

A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma

HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma

A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2

A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma

Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors

B7-H3.CD28Z.CART in CNS Neoplasms